At the close of the Challenge, shortlisted ideas will be evaluated against the eligibility criteria by a selection panel that includes Sanofi Genzyme and Regeneron, healthcare innovators and experts in AD, as well as the OpenIDEO Challenge team. This will be followed by a period of due diligence and grant review process before signing an agreement.

SAGLB.AD.19.08.1277(1) | September 2019